LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | BI-2536 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 846 | 3769 | 0.2246 | -0.0938 |
BT-20 | BMS345541 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3421 | 3769 | 0.9077 | 0.8698 |
BT-20 | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 1048 | 3769 | 0.2781 | -0.0183 |
BT-20 | GDC-0980 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 984 | 3769 | 0.2611 | -0.0423 |
BT-20 | NVP-AEW541 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3912 | 3769 | 1.0378 | 1.0533 |
BT-20 | SB590885 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3896 | 3769 | 1.0337 | 1.0476 |
BT-20 | PIK-93 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 4017 | 3769 | 1.0656 | 1.0926 |
BT-20 | KIN001-043 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3483 | 3769 | 0.9240 | 0.8928 |
BT-20 | Alpelisib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3808 | 3769 | 1.0103 | 1.0145 |
BT-20 | Luminespib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 1164 | 3769 | 0.3090 | 0.0252 |
BT-20 | A443654 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 1500 | 3769 | 0.3981 | 0.1510 |
BT-20 | OSI-027 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 2885 | 3769 | 0.7654 | 0.6690 |
BT-20 | XMD11-85h | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3201 | 3769 | 0.8492 | 0.7873 |
BT-20 | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 2796 | 3769 | 0.7417 | 0.6357 |
BT-20 | WH-4-025 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3344 | 3769 | 0.8872 | 0.8409 |
BT-20 | WZ-4-145 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 2948 | 3769 | 0.7821 | 0.6926 |
BT-20 | XMD16-144 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 1569 | 3769 | 0.4163 | 0.1767 |
BT-20 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3567 | 3769 | 0.9465 | 0.9245 |
BT-20 | Buparlisib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3018 | 3769 | 0.8007 | 0.7189 |
BT-20 | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3707 | 3769 | 0.9835 | 0.9767 |
BT-20 | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3273 | 3769 | 0.8685 | 0.8144 |
BT-20 | Celastrol | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3935 | 3769 | 1.0439 | 1.0619 |
BT-20 | CGP60474 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 932 | 3769 | 0.2473 | -0.0617 |
BT-20 | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 663 | 3769 | 0.1760 | -0.1624 |
BT-20 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3254 | 3769 | 0.8633 | 0.8072 |